Please Wait

Applying Filters...

Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

Stock Recap
#PipelineProspector

Cefepime Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 9 USDMF, 1 CEP/COS, 8 JDMF, 1 EU WC, 15 KDMF, 7 NDC API, 3 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

46 FDF Dossiers, 27 FDA Orange Book, 2 Europe, 3 Canada, 10 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl, 2 Kirsch Pharma, 1 Actylis, 1 Pluviaendo, 4 Roquette

EXCIPIENTS BY APPLICATIONS

5 Parenteral, 2 Fillers, Diluents & Binders, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 2 Regulatory FDF Prices

MARKET PLACE

8 APIs

8 APIs

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
17/09/2025	Orchid Pharma	India	M/s. Orchid Pharma Limited	WC-0131	Cefepime Hydrochloride with L-Arginine forInjectable Formulation USP	2025-08-01	2028-07-21	Plot No.121-128, 128A-133,138-151 & 159-164,\\nSIDCO Industrial Estate Alathur,\\nChengalpattu-603110, Tamil Nadu India

Contact us
to update this info

Cefepime Hydrochloride

Cefepime Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers

9 USDMF

1 CEP/COS

8 JDMF

1 EU WC

15 KDMF

7 NDC API

3 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

46 FDF Dossiers

27 FDA Orange Book

2 Europe

3 Canada

10 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl

2 Kirsch Pharma

1 Actylis

1 Pluviaendo

4 Roquette

EXCIPIENTS BY APPLICATIONS

5 Parenteral

2 Fillers, Diluents & Binders

1 API Stability Enhancers

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions

2 Regulatory FDF Prices

MARKET PLACE

8 APIs

REF. STANDARDS & IMPURITIES

1 USP

1 Others

Filters

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons